Skip to main content

Table 4 Measures of SEP impact PAF% and PAFa of each disease by sex in children in Catalonia

From: Socioeconomic inequalities in 29 childhood diseases: evidence from a 1,500,000 children population retrospective study

Disease PAF% (95% CI) PAFa (95% CI)
Boys Girls Boys Girls
Infectious diseases
 Tuberculosis 56.26 (43.03, 66.41) 51.95 (38.51, 62.45) 181 (139, 214) 171 (127, 205)
 Meningitis (bacterial or viral) 18.32 (5.88, 29.11) 7.69 (−9.09, 21.90) 93 (30, 148) 24 (−28, 67)
 Influenza 7.17 (6.13, 8.20) 7.83 (6.73, 8.91) 4540 (3882, 5191) 4450 (3827, 5065)
Neoplasms
 Cancer of the brain and nervous system 0.54 (−19.66, 17.34) 6.69 (−14.89, 24.21) 1 (−44, 39) 13 (−29, 47)
 Leukaemia −1.77 (− 18.54, 12.63) 5.93 (− 13.30, 21.90) − 6 (− 60, 41) 14 (− 32, 53)
 Malignant neoplasms 7.51 (1.57, 13.10) 9.18 (2.85, 15.10) 166 (35, 290) 177 (55, 291)
Anthropometrics
 Overweight 15.63 (14.74, 16.52) 18.44 (17.46, 19.40) 10,905 (10,280, 11,524) 10,872 (10,299, 1438)
 Obesity 27.14 (25.86, 28.39) 30.31 (28.77, 31.80) 9407 (8694, 9841) 7204 (6840, 7560)
Mental health
 Mood disorders 20.11 (15.29, 24.65) 21.54 (16.96, 25.86) 619 (471, 759) 718 (565, 862)
 Adjustment and anxiety disorders 22.88 (21.42, 24.31) 23.30 (21.76, 24.81) 6964 (6520, 7400) 6290 (5873, 6699)
 ADHD 4.01 (2.31, 5.68) 7.34 (4.46, 10.13) 1031 (595, 1459) 658 (399, 908)
 ASD 7.04 (3.63, 10.33) 8.57 (0.84, 15.69) 459 (237, 673) 113 (11, 207)
Autoimmune and respiratory diseases
 Acute bronchitis 10.30 (9.63, 10.96) 11.11 (10.35, 11.87) 14,082 (13,174, 14,983) 11,905 (11,091, 12,713)
 Chronic bronchitis 10.30 (9.27, 11.32) 11.52 (10.35, 12.68) 6540 (5887, 7187) 5665 (5089, 6234)
 Asthma 1.15 (0.03, 2.31) 5.16 (3.69, 6.61) 594 (16, 1196) 1714 (1225, 2194)
 Respiratory allergy 6.93 (6.01, 7.83) 9.59 (8.59, 10.58) 2335 (2026, 2641) 2295 (2056, 2532)
 Dermatitis 9.69 (9.13, 10.25) 11.61 (11.06, 12.15) 15,345 (14,457, 16,227) 19,027 (18,128, 19,921)
 Food allergy −5.42 (−7.07, −3.80) −4.46 (−6.22, −2.73) − 524 (− 683, − 367) − 401 (− 559, − 246)
 Cystic fibrosis −5.12 (− 32.35, 16.51) −8.90 (− 37.10, 13.50) −7 (− 43, 22) −11 (− 47, 17)
Adverse birth outcomes
 Short gestation, low birth weight,foetal growth retardation 29.83 (26.78, 32.75) 28.21 (24.98, 31.29) 2053 (1843, 2254) 1757 (1556, 1949)
 Intrauterine hypoxia and birth asphyxia and trauma 30.04 (25.40, 34.39) 32.10 (26.54, 37.24) 915 (774, 1048) 675 (558, 783)
 Congenital anomalies 11.51 (10.55, 12.45) 8.19 (7.10, 9.26) 8305 (7615, 8988) 4742 (4115, 5362)
Nervous system
 Paralysis 18.50 (10.39, 25.88) 11.37 (1.81, 20.00) 211 (118, 295) 98 (16, 173)
 Epilepsy 11.22 (6.86, 15.38) 6.11 (1.21, 10.78) 443 (270, 607) 196 (39, 346)
Circulatory system
 Essential hypertension 24.81 (17.73, 31.28) 24.64 (16.36, 32.10) 351 (251, 443) 257 (171, 335)
 Heart valve disorders 5.62 (3.87, 7.34) 6.39 (4.43, 8.31) 1340 (921, 1750) 1218 (844, 1584)
 Acute cerebrovascular disease 17.09 (5.93, 26.93) 7.09 (−6.98, 19.31) 107 (37, 169) 30 (−30, 82)
Others
 Injuries 7.54 (7.10, 7.98) 7.17 (6.67, 7.68) 19,432 (18,303, 20,555) 14,758 (13,714, 15,796)
 Poisoning 20.81 (14.22, 26.90) 27.82 (21.26, 33.84) 347 (237, 449) 442 (337, 537)
  1. Note: PAF% and PAFa were calculated using medium-high SEP category as a reference group
  2. ADHD attention deficit hyperactivity disorder, ASD autism spectrum disorder